XPO (NYSE: XPO), a leading provider of freight transportation in North America, today announced that its Board of Directors ...

Anaptys has cash, cash equivalents and investments greater than $420 million as of December 31, 2024, and anticipates receipt of a $75 million commercial sales milestone payment from GSK in 2025 or ...

Corporation announced that its Board of Directors has authorized a new share repurchase program under which the company may ...

Engine Capital, which said it owns about 9.8% of Civeo’s shares, urged the company’s board of directors to make a series of ...

Thursday announced that its Board of Directors has determined to resume repurchases of shares of the company’s common stock.

The company, based in Bethlehem, said in a news release that its board of directors has authorized the buyback of its common stock using cash on hand over the next 24 months. The amount and timing ...

AnaptysBio, Inc. has announced a Stock Repurchase Plan allowing for the buyback of up to $75 million of its common stock. As of the end of 2024, the company reports having over $420 million in ...

Shares of AnaptysBio (NASDAQ: ANAB) climbed 12% today as the company announced a significant stock repurchase plan, signaling confidence in its financial position and future prospects. The ...

Initial Program Puts in Place Mechanism Enabling Deployment of Proceeds from IP Defense to Repurchase Common Stock ...

The Stock Repurchase Plan will expire on December 31, 2025, may be suspended or discontinued at any time, and does not obligate the company to acquire any amount of common stock. This press ...